Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation.
Saved in:
| Title: | Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. |
|---|---|
| Authors: | TeBay C; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia., McArthur JR; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia., Mangala M; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Kerr N; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Heitmann S; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia., Perry MD; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; School of Medical Sciences, UNSW Sydney, Sydney, New South Wales, Australia., Windley MJ; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Vandenberg JI; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Hill AP; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2022 Jun; Vol. 179 (11), pp. 2631-2646. Date of Electronic Publication: 2022 Jan 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-5381 |
|---|---|
| DOI: | 10.1111/bph.15757 |
